Global Natural Killer Cells Therapeutics Market to Be Dominated by Natural Killer Cell Directed Antibodies Segment Through 2027
Increasing
prevalence of chronic diseases such as cancer is expected to drive the growth
of global natural killer cells therapeutics market in the forecast period,
2023-2027.
According to
TechSci Research report, “Natural killer
Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2017-2027”,
the global natural killer cells therapeutics market
is anticipated to grow at an impressive rate in the forecast period, 2023-2027.
This can be ascribed to the rising aging population susceptible to various
chronic diseases such as heart disease, arthritis, diabetes, stroke, cancer,
among others. Besides, changing lifestyle patterns, adoption of sedentary
lifestyle, unhealthy eating habits, among others are further contributing
towards different diseases requiring an effective and permanent treatment. This has made the research fraternity across
the globe to shift their focus in developing effective treatment for these
diseases and finding the best curative treatment option. This in turn is
expected to create lucrative opportunities for the growth of new treatment
options such as natural killer therapeutics market over the coming next few
years.
However, lack of specificity and
poor in-vivo survival of the natural killer cells may hamper the market growth.
Similarly, lack of specificity among natural killer cells leads to targeting
the wrong cells thereby making the treatment ineffective thereby restricting
the market growth. Besides, lack of awareness and affordability constraints
especially in the emerging countries can further slow down the market growth of
global natural killer cells therapeutics market.
Browse over XX market data Figures spread through 110 Pages and an in-depth
TOC on "Natural Killer Cells Therapeutics Market"
The global natural killer cells therapeutics market can be segmented by type, by application, by end user and by region.
Based on application, the global natural killer cells therapeutics market can be segmented into cancer, gastrointestinal diseases,
immunoproliferative disorders, and others. The cancer application is expected to
dominate the market during the forecast period. This can be attributed to the
growing prevalence of different forms of cancers worldwide. Additionally, increase in adoption of natural
killer cells therapies for treatment of various types of cancers such as acute
myeloid leukemia, Hodgkin’s lymphoma, hematologic malignancies, solid tumors,
cutaneous T cell lymphoma and head and neck cancer is expected to support the
segmental growth and overall natural killer cells therapeutics market.
Based on end user, the global natural killer cells therapeutics market can be segmented into hospitals & clinics, academic
& research institutions, and others. The academic and research institute segment
is predicted to dominate the market in the forecast period. This can be
ascribed to the growing research & development activities conducted by
these organizations to develop an effective natural killer cells therapeutic
solution for treatment of different diseases.
Major
companies operating in global natural killer cells therapeutics market are:
- Affimed N.V.
- Century Therapeutics,
Inc.
- Celularity Inc.
- Cytovac A/S
- Dragonfly Therapeutics,
Inc.
- Fate Therapeutics, Inc.
- Gamida Cell Ltd.
- ImmunityBio, Inc.
- Innate Pharma SA
- Nkarta, Inc.
- Sanofi S.A.
- Takeda Pharmaceutical
Company Limited
- VaxCell Biotherapeutics
Co., Ltd.
- Acepodia Inc.
- Glycostem Therapeutics
B.V.
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“The North America is expected to dominate the global natural killer cells
therapeutics market on account of the growing prevalence of cancer in the
region. Additionally, increasing research & development activities in the
region for the development of natural killer cells therapeutics especially in
the United States is expected to create lucrative opportunities for the market
growth in the coming years” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Natural Killer Cells Therapeutics Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed
Antibodies), By Application (Cancer, Gastrointestinal Diseases,
Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic &
Research Institutions, Others) and By Region”, has evaluated the future growth potential of
global natural killer cells therapeutics market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global natural killer cells therapeutics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com